| Israele | Turchia | Austria | |
| Trapianto di midollo osseo allogenico da donatore non correlato | da $135,000 | da $80,000 | da $180,000 |
| Trapianto di midollo osseo allogenico da donatore consanguineo | da $142,000 | da $65,000 | da $150,000 |
| Trapianto di midollo osseo | da $144,000 | da $36,000 | da $140,000 |
| Trapianto autologo di midollo osseo | da $58,000 | da $31,500 | da $50,000 |
| Terapia con cellule CAR-T | da $72,000 | da $150,000 | da $350,000 |
Esperto di linfomi presso il Sourasky Medical Center con oltre 30 anni di esperienza specializzata in oncologia.
Il medico è un ostetrico e ginecologo altamente esperto con oltre 25 anni nel campo. Specializzandosi in Medicina della Riproduzione in Ostetricia e Ginecologia, il medico è esperto in trattamenti come Inseminazione Intrauterina (IUI), Procedura di Induzione dell'Ovulazione, Perforazione Ovarica e gestione delle Valvole Uretrali.<\/p>
Il medico ha completato una borsa di studio presso il Ronald O Perelman e Claudia Cohen Centre, possiede un diploma dall'Irlanda e ha conseguito un MBBS presso l'Università di Mysore, India.<\/p>
Il medico è il capo del Dipartimento di Oncoematologia e Oncologia Pediatrica presso l'Ospedale Pediatrico Dana Dwek. Specializzandosi in trapianti di midollo osseo e sangue del cordone ombelicale per bambini, il medico ha effettuato oltre 300 trapianti. Con una forte presenza accademica, il medico ha pubblicato 50 articoli e presentato 40 relazioni in varie conferenze mediche. Il medico è membro dell'Associazione Americana di Ematologia e della Società Israeliana di Emato-oncologia Pediatrica, e ha praticato presso il City of Hope Hospital di Los Angeles e in vari centri medici in Israele.<\/p>
Il medico è certificato dal consiglio in Medicina Interna, Ematologia e Oncologia Medica. Il percorso professionale include una residenza presso la State University of New York a Brooklyn e una borsa di studio in Ematologia e Oncologia presso il New York Medical College, Westchester Medical Center.<\/p>
Con un forte impegno nel campo medico, il medico ha pubblicato oltre 30 articoli scientifici e ha contribuito a un capitolo di un libro di testo medico. La competenza è ulteriormente dimostrata dall'esecuzione di diverse centinaia di trapianti di cellule staminali, evidenziando l'esperienza in questo settore.<\/p>
Israel achieves highly accurate lymphoma staging through rigorous pathology re-evaluation and high-resolution imaging. Facilities like Sheba Medical Center use fused PET-CT scans with 98.2% accuracy. This precise subtyping identifies the exact biological profile. This ensures treatments match the specific lymphoma variant from the start.
Bookimed Expert Insight: Data shows Israeli centres like Sheba and Sourasky prioritize internal pathology reviews over previous results. Even if patients bring reports, specialists often request the original biopsy slides for re-testing. This focus on absolute accuracy is why Dr Abraham Avigdor can achieve such precise outcomes for complex, resistant lymphoma cases.
Patient Consensus: Patients in Israel note that doctors often re-run biopsies and imaging to confirm the exact subtype. This thoroughness is appreciated as it ensures the correct treatment starts immediately without delays or guesswork in Tel Aviv.
Israel offers advanced lymphoma treatments including homegrown CAR T-cell therapy, allogeneic bone marrow transplants, and precision chemo-biologic protocols. Major JCI-accredited centres like Sheba Medical Center and Sourasky Medical Center provide targeted biological therapies. These protocols achieve 100% one-year survival for certain Hodgkin lymphoma stages.
Bookimed Expert Insight: Sheba Medical Center is ranked 7th worldwide and leads in CAR-T research. Specialists like Dr Abraham Avigdor, who heads the Israeli Lymphoma Working Group, offer decades of experience. Patients should note that Sheba also provides a paediatric-specific CAR-T program for primary CNS lymphoma.
Patient Consensus: Patients find value in expert oncohematology teams and modern PET-CT imaging for precise staging. Most recommend transferring pathology reports and biopsy results before departure to ensure immediate treatment in Israel.
Israel offers advanced lymphoma treatment through rapid access to CAR-T cell immunotherapy and pioneering clinical research. JCI-accredited hospitals such as Sheba Medical Center are global leaders in haematology-oncology. They provide comprehensive care including bone marrow transplants and precise molecular diagnostics for complex relapsed cases.
Bookimed Expert Insight: Israeli centres specialise in resistant or relapsed cases that other regions might find difficult. Doctors like Dr Abraham Avigdor integrate CAR-T and TIL immunotherapy into standard protocols. Our data shows Sheba Medical Center serves 2,000,000+ patients annually. This massive volume ensures specialists have experience with even the rarest lymphoma subtypes.
Patient Consensus: Patients value how quickly they can get expert second opinions on staging and pathology. They note that bringing full medical records and slides makes the specialist review smoother. The emotional relief of confirming a diagnostic plan with world leaders in Israel helps reduce anxiety significantly.
Sheba Medical Center and Sourasky Medical Center (Ichilov) are Israel's leading institutions for lymphoma care. These JCI-accredited facilities specialise in CAR-T cell immunotherapy and bone marrow transplants. They report high remission rates using advanced molecular diagnostics and targeted biological therapies.
Bookimed Expert Insight: While many centres offer general oncology, Israeli facilities like Sheba and Sourasky provide highly specific CAR-T programs for rare subtypes like primary CNS lymphoma. These packages, starting around A$110,400, typically include 21 days of hospitalisation and 24-hour nursing care. Such intensive monitoring is vital during the critical T-cell infusion phase to manage immune responses effectively.
Patient Consensus: Patients note that Israel's major academic hospitals provide clear explanations and better-than-expected results. They emphasise bringing digital medical records and coordinating pathology transfers before travelling to Jerusalem or Tel Aviv for treatment.
Lymphoma treatment in Israel typically lasts from 5 days for diagnosis to 9 months for intensive protocols. Diagnostic planning at centres like Sheba Medical Center takes 3 to 5 business days. Advanced CAR T-cell therapy requires 21 to 30 days of supervised care.
Bookimed Expert Insight: Israeli oncology packages often bundle extended hospital stays for safety. Sheba Medical Center packages include up to 30 days of hospitalisation for transplants. This ensures specialists like Dr Abraham Avigdor can monitor blood counts daily during the critical recovery phase.
Patient Consensus: Patients note that testing takes time, so bringing previous pathology records helps speed up care. Most travellers visiting Israel recommend staying for the full initial cycle to manage side effects with staff.
Language barriers will not interfere with lymphoma treatment in Israel. English is the standard for medical training and global research there. Specialists are highly fluent and communicate directly in English. Patients receive dedicated coordinators to manage documentation and translate administrative paperwork throughout their stay.
Bookimed Expert Insight: While doctors are fluent, administrative paperwork handling varies between cities. Specifically, major centres in Tel Aviv and Ramat Gan have larger international departments. These clinics, like Sheba Medical Center, include dedicated English-speaking coordinators in their specialized CAR-T lymphoma packages to bridge any minor communication gaps during hospital stays.
Patient Consensus: Patients find the English level in Israel excellent for medical care. They note that having a coordinator for chasing test results and explaining billing details is helpful. Most people recommend asking for written treatment plans in plain English after every meeting to stay organized.